U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H11I3N2O4.C7H17NO5
Molecular Weight 823.1537
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METRIZOATE MEGLUMINE

SMILES

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CN(C(C)=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I

InChI

InChIKey=TXKOGNLDVKUFSI-WZTVWXICSA-N
InChI=1S/C12H11I3N2O4.C7H17NO5/c1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-3H3,(H,16,18)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1

HIDE SMILES / InChI

Molecular Formula C12H11I3N2O4
Molecular Weight 627.9402
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C7H17NO5
Molecular Weight 195.2136
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Metrizoic acid is a diagnostic radiopaque that usually occurs as the sodium salt. The mechanism of action of metrizoic acid is as a X-Ray Contrast Activity.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
ISOPAQUE 280

Approved Use

Unknown

Launch Date

1.36511996E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
300 μg/mL
2310 mg single, intravenous
dose: 2310 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
METRIZOIC ACID serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
250 μg × h/mL
2310 mg single, intravenous
dose: 2310 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
METRIZOIC ACID serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
75.1 min
2310 mg single, intravenous
dose: 2310 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
METRIZOIC ACID serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
100%
2310 mg single, intravenous
dose: 2310 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
METRIZOIC ACID serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
Increased ventricular fibrillation during coronary arteriography with a new contrast medium preparation.
1971 Oct
Adverse general reactions to high doses of methylglucamine-based contrast media.
1974 Sep
ECG changes and arrhythmias induced by ionic and non-ionic contrast media during coronary arteriography in dogs.
1978 May-Jun
Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure.
1987

Sample Use Guides

0.35 mg/ml; 140.1 mg/ml; 461.8 mg/ml
Route of Administration: Intravascular
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 14:57:37 UTC 2023
Edited
by admin
on Fri Dec 15 14:57:37 UTC 2023
Record UNII
RJY6JR42WQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METRIZOATE MEGLUMINE
Common Name English
MEGLUMINE METRIZOATE
MART.   ORANGE BOOK   WHO-DD  
Common Name English
MEGLUMINE METRIZOATE [ORANGE BOOK]
Common Name English
BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, COMPD. WITH D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)- (1:1)
Common Name English
MEGLUMINE METRIZOATE [MART.]
Common Name English
Meglumine metrizoate [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C390
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
Code System Code Type Description
DRUG BANK
DBSALT001369
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
SMS_ID
100000086396
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
MESH
C021342
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
FDA UNII
RJY6JR42WQ
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
EVMPD
SUB03123MIG
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
PUBCHEM
10056264
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
ChEMBL
CHEMBL1736
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
CAS
7241-11-4
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
ECHA (EC/EINECS)
230-641-3
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
NCI_THESAURUS
C95058
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
EPA CompTox
DTXSID40993205
Created by admin on Fri Dec 15 14:57:37 UTC 2023 , Edited by admin on Fri Dec 15 14:57:37 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY